MedPath

Nefopam Hydrochloride

Generic Name
Nefopam Hydrochloride

Dose Ranging Study to Evaluate the Safety and Tolerability of SCX-001 Cream in Healthy Volunteers With Induced Dermal Incisions

Phase 1
Completed
Conditions
Scarring
Interventions
Other: Placebo
First Posted Date
2017-01-30
Last Posted Date
2017-10-04
Lead Sponsor
ScarX Corp
Target Recruit Count
24
Registration Number
NCT03036306
Locations
🇨🇦

University of Alberta Hospital, Edmonton, Alberta, Canada

© Copyright 2025. All Rights Reserved by MedPath